Izalgi analgesic

Izalgi is a specialized pharmaceutical product used for the management of moderate to severe pain. It is a combination medication typically consisting of paracetamol and powdered opium. The brand and formulation were developed within the French medical market to address specific analgesic needs where standard over-the-counter options were insufficient.

The product is manufactured in France, adhering to strict European healthcare regulations and pharmaceutical standards. It is a key part of the therapeutic portfolio for pain management in the region, distributed primarily through clinical and pharmacy networks under prescription guidelines.

Izalgi is owned and produced by Sanofi, one of the world's largest healthcare companies. Sanofi, headquartered in Paris, manages the brand's global distribution and research, ensuring that the medication meets modern safety and efficacy protocols as part of their diverse general medicines category.